Schweizerische Gesellschaft für Kardiologie
Société Suisse de Cardiologie
Società Svizzera di Cardiologia

Gemeinsame Jahrestagung 2017:
Schweizerische Gesellschaft für Kardiologie (SGK) und Schweizerische Gesellschaft für Herz- und thorakale Gefässchirurgie (SGHC)

7. - 9. Juni 2017, Trafo Baden





Programm vom Donnerstag, 11.06.2015


Zeit Session Raum
07:30 - 08:00 Satellite Symposium Seezimmer 2
  Servier (Suisse) SA: What`s new in the hypertension management?  
What`s new in the hypertension management?  

St. Rimoldi (Bern, CH); R. Brenner (St. Gallen, CH)

08:00 - 09:00 Abstract Session 4 Panoramasaal
  Novel approaches in valvular, vascular and cardiac disease
  Vorsitz/Modération: R. Klingenberg (Zürich, CH), S. Puricel (Freibourg, CH)  
  Prediction of artificial chordae length by transesophageal echocardiography in non-resective mitral valve repair: A simple method for isolated P2 prolapse  

A. Weber 2,*, H. Kaiser 1, Th. Carrel 2, S. Hurni 2, B. Eberle 1

  1Anaesthesiology, 2Cardiovascular Surgery, Inselspital, Bern, Switzerland  
  Only neochordoplasty achieves physiological trans-valvular pressure gradients after repair of acute posterior leaflet prolapse in porcine mitral valves  

S. Hurni 1,*, S. Jahren 3 on behalf of equally contributed, S. Vandenberghe 2, Th. Carrel 1, D. Obrist 3, A. Weber 1

  1Cardiovascular Surgery, 2Artorg, Inselspital, 3Artorg, University of Bern, Bern, Switzerland  
  Aortic tissue-derived secretome profiling towards biomarkers for acute aortic dissection  

J. Gawinecka 1,*, F. Schönrath2, 3, H. Reiser1, E. Arvaniti4, V. Falk2, 3, M. Claassen4, A. von Eckardstein1

  1Clinical Chemistry, 2Cardiovascular Surgery, University Hospital, Zürich, Switzerland, 3Cardiothoracic and Vascular Surgery, German Heart Institute, Berlin, Germany, 4Molecular Systems Biology, ETH, Zürich, Switzerland  
  Upregulation of pro-apoptotic perp, pro-adipogenic CPT1B and phospholamban in myocardial tissue of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to dilated cardiomyopathy

D. Akdis 1,*, A. M. Saguner 1, J. Kast 2, A. Medeiros-Domingo 1, F. Enseleit 1, P. Bode 3, K. Klingel 4, C. Akdis 2, C. Brunckhorst 1, F. Duru 1

  1University Heart Center, Zürich, 2Swiss Institute of Allergy and Asthma Research, Davos, 3Pathology, University Hospital, Zürich, Switzerland, 4Molecular Pathology, University Hospital, Tübingen, Germany  
08:00 - 09:00 Satellite Symposium Kammermusiksaal
  Boston Scientific & Medtronic: TAVI - Repositionability, the Game Changer?  

Vorsitz/Modération: F. Nietlispach (Zürich, CH); P. Wenaweser (Bern, CH)  
Panel: M. Moccetti (Lugano, CH); F. Eberli (Zürich, CH); St. Noble (Genève, CH); J. Grünenfelder (Zürich, CH)  
1-2 BSC Technology & Cases & Discussion  
R. Jeger (Basel, CH)  
1-2 MDT Technology & Cases & Discussion  
St. Toggweiler (Luzern, CH)  
08:00 - 09:00 Workshop 5 Seezimmer 3
  Swiss Hypertension Guidelines  
  Vorsitz/Modération: I. Sudano (Zürich, CH); F. Mugli (Vezia, CH)  
08:00 - 09:00 Abstract Session 5 Seezimmer 4
  Clinical cases "lost and found"  
  Vorsitz/Modération: Ch. Huber (Bern, CH), P. Monnier (La Chaud-de-Fonds, CH )  
  Percutaneous transcatheter closure with the new amplatzer vascular plug iii for closure of an accidental aortic puncture and infectious paravalvular leak  

B. Winkler 2 *, B. Meier 1, Th. Carrel 2, Ch. Huber 2

  1Cardiology, 2Cardiovascular Surgery, Inselspital, Switzerland  
  Successful surgical pulmonary embolectomy for massive perinatal embolism after emergency cesarean section  

L. Niclauss*, S. Colombier, R. Prêtre


CHUV, Lausanne, Switzerland

  Magnetic resonance tissue characterization of a left atrial mass in a carcinoma patient  

B. De Boeck 1,*, M. Hoffmann 2, M. Paul 1, R. Kobza 1


1Cardiology, 2Radiology, Cantonal Hospital, Luzern, Switzerland

  Carbon monoxide intoxication as a rare cause of cardiogenic shock  
  K. Hasni*, A. Testuz, R. Pignel, Ph. Meyer, M. Namdar  

University Hospital, Genève, Switzerland

09:15 - 10:45 Main Session 3 Panoramasaal
  Perioperative myocardial infarction  
  Vorsitz/Modération: M. Filipovic (St. Gallen, CH); Th. Lüscher (Zürich, CH)  
  Prevention, epidemiology and prognosis of perioperative myocardial injury  
  PJ. Devereaux (Toronto, CA)  
  Invasive versus conservative approach in patients undergoing vascular surgery: Anaesthesiologist's view  
  B. Biccard (Mayville, ZA)  
  Invasive versus conservative approach in patients undergoing vascular surgery: Cardiologist's view  
  H. Rickli (St. Gallen, CH)  
  Closing remarks  
  M. Filipovic (St. Gallen, CH)  
09:15 - 10:45 Workshop 6 Kammermusiksaal
  State of the art and future of dyslipidemia management  
  Vorsitz/Modération: R. Darioli (Lausanne, CH); G. Noll (Zürich, CH)  
FH - The catapult to high risk  
E. Bruckert (Paris, FR)  
Success and limitations of current hypolipidemic drug therapy  
W. Riesen (Diessenhofen, CH)  
PCSK9 Inhibitors: Ready for primetime?  
F. Mach (Genève, CH)  
Any need of lipid modifying drug therapy beyond lowering of LDL-cholesterol?  
  A. von Eckardstein (Zürich, CH)  
09:15 - 10:45 Workshop 7 Vortragssaal
  Fast track in cardiac surgery  
  Vorsitz/Modération: B. Eberle (Bern, CH); F. Eckstein (Basel, CH)  
  Fast track: Definition & outcome  
  J. Fassl (Basel, CH)  
  Patient selection & perioperative management  
  S. Matter-Ensner (Zürich, CH)  
  The role of the surgeon  
  E. Ferrari (Lausanne, CH)  
  How long in ICU?  
  T. Cassina (Lugano, CH)  
09:15 - 10:45 Scientific Session 1 Seezimmer 3
  What confusion after heart surgery / multiple faces of delirium - How must we react?  
  Vorsitz/Modération: S. Bischoff (Bern, CH); M. Leventhal (Pfäffingen, CH)  
  Different types of delirium: What are the differences? Or How do we differentiate between them and are there differences in outcomes?  
  D. Adamis (Athens, GR)  
  Instruments used to detect delirium  
  M. Schuurmans (Utrecht, NL)  
  Alcohol withdrawal – A challenge in caring for patients after heart surgery  
  W. Hasemann (Basel, CH)  
  Delirium Path: Effectiveness, efficiency, costs and value of standardised guidelines for Delirium-Management in the Intensive Care Units  
  M. Schubert (Zürich, CH)  
09:15 - 10:45 Abstract Session 6 Seezimmer 2
  Clinical Cases in Rhythmology  
  Vorsitz/Modération: M. Zuber (Othmarsingen, CH), Martin Rotter (Bern, CH)  
  Malignant mitral valve prolapse mixes up features of primary electrical disorder and mild structural heart disease  

E. Pruvot*, L. Bisch, Ch.-I. Park, P. Pascale


CHUV, Lausanne, Switzerland

  Epicardial catheter ablation of ventricular tachycardia in a patient with non-ischemic cardiomyopathy  

L. M. Haegeli*, C. Brunckhorst


University Hospital, Zürich, Switzerland

  Isolated reduced expression of desmoplakin manifesting as recurrent ventricular tachycardia  from the right ventricle epicardium  

S. Rosset 1,*, D. Graf 1, M. Jacques 2, E. Pruvot 1


1Cardiology, CHUV, Lausanne, 2Cardiology, Clinique des Grangettes, Chêne-Bougeries, Switzerland

  Superior vena cava fibrillation maintains slow atrial fibrillation and persists after superior vena cava isolation with restoration of sinus rhythm  

A. Lam*, J. Fuhrer, A. Medeiros-Domingo, J. Seiler, H. Servatius, F. Noti, N. Tran, H. Tanner, L. Roten


Cardiology, Inselspital, Bern, Switzerland

  First defibrillation ever of a high - Frequency ventricular tachycardia by a Lifevest® in Switzerland  

N. Susuri*, H. Servatius, N. Tran, L. Roten, F. Noti, H. Tanner, J. Seiler, A. Medeiros, M. Martinelli, A. Lam, J. Fuhrer


Cardiology, Inselspital, Bern, Switzerland

  X-ray free implantation of a permanent pacemaker during pregancy using a 3D electro-anatomic mapping system  

A. Mühl 1 *, T. Reichlin 1, B. Schaer 1, S. Knecht 1, C. Ramazzina 2, J. Novak 3, St. Osswald 1, Ch. Sticherling 1, M. Kühne 1


1Cardiology, University Hospital, Basel, 2Cardiology, Cantonal Hospital, Olten, 3Cardiology, Bürgerspital, Solothurn, Switzerland

09:15 - 10:45 Abstract Session 7 Seezimmer 4
  Bioabsorbable scaffolds and more  
  Vorsitz/Modération: Ch. Röthlisberger (Biel, CH), R. Jeger (Basel, CH)  
  Bioabsorbable polymer-coated thin strut everolimus-eluting synergy stent for coronary revascularization in daily clinical practice: One year results of the sweet registry  

S. Puricel 1 *, L. Räber 2, D. Heg 2, M. Stadelmann 1, Th. Zanchin 2, Ph. Urban 3, E. Boute 1, P. Wenaweser 2, M. Togni 1, E. De Benedetti 3, St. Windecker 2, St. Cook 1


1University and Hospital of Fribourg, Fribourg, 2Inselspital, Bern, 3La Tour Hospital, Genève, Switzerland

  Which patients benefit from biodegradable-polymer drug-eluting stents? – A subgroup analysis from a prospective long-term clinical trial  

M. Bossard 1 *, R. Jeger 1, N. Gilgen 1, F. R. Eberli 4, D. J. Kurz 4, G. Pedrazzini 5, T. Moccetti 5, H. Rickli 4, D. Weilenmann 6, A. G. Vuilliomenet 7, M. Steiner 7, St. Von Felten 2, D. R. Vogt 2, P. Rickenbacher 8, D. Conen 3, Ch. Müller 1, P. Buser 1, A. Hoffmann 1, M. Pfisterer 1, Ch. Kaiser 1 on behalf of The Basket Investigators


1Cardiology, 2Clinical Trial Unit, 3Internal Medicine, University Hospital, Basel, 4Cardiology, Triemli Hospital, Zürich, 5Cardiology, Cardiocentro Ticino, Lugano, 6Cardiology, Cantonal Hospital, St.Gallen, 7Cardiology, Cantonal Hospital, Aarau, 8Cardiology, Cantonal Hospital, Bruderholz, Switzerland

  Vascular response to everolimus- and biolimus-eluting coronary stents vs. Everolimus-eluting bioresorbable scaffolds - An optical coherence tomography substudy of the everbio II trial  

Z. Kallinikou*, D. Arroyo, M. Togni, S. Lehmann, N. Corpataux, M. Cook, O. Müller, G. Baeriswyl, J.-C. Stauffer, J.-J. Goy, S. Puricel, St. Cook

  University and Hospital of Fribourg, Fribourg, Switzerland  
  Clinical parameters do not predict thrombosis after implantation of bioresorbable vascular scaffolds, but introduction of a specific implantation strategy is associated with a significant reduction in its incidence  

F. Cuculi 1 *, S. Puricel 2, P. Jamshidi 1, J. Obitz 3, M. Weissner 3, H. Eggebrecht 3, A. Schmermund 3, Th. Münzel 3, St. Cook 2, T. Gori 3


1Heart Center, Cantonal Hospital, Luzern, 2Cardiology, Hospital of Fribourg, Fribourg, Switzerland, 3Cardiology, University Hospital, Mainz, Germany

  Improved clinical outcomes of patients aged ≥75 years treated with drug-eluting stents compared to bare metal stents in large coronary arteries: Results from the basket-prove randomized trail  

D. J. Kurz 1,*, A. M. Bernheim 1, D. Tüller 1, R. Zbinden 1, R. Jeger 2, Ch. Kaiser 2, S. Galatius 3, K. W. Hansen 3, H. Alber 4, M. Pfisterer 2, F. R. Eberli 1


1Cardiology, Triemli Hospital, Zürich, 2Cardiology, University Hospital, Basel, Switzerland, 3Cardiology, Gentofte University Hospital, København, Denmark, 4Cardiology, University Hospital, Innsbruck, Austria

  Optical coherence tomography findings in bioresorbable vascular scaffold thrombosis  

F. Cuculi 1 *, S. Puricel 2, P. Jamshidi 1, J. Valentin 2, Z. Kallinikou 2, St. Toggweiler 1, M. Weissner 3, Th. Münzel 3, T. Gori 3, St. Cook 2


1Cantonal Hospital, Luzern, 2University and Hospital of Fribourg, Fribourg, Switzerland, 3University Medical Center, Mainz, Germany

11:00 - 12:30 Main Session 4 Panoramasaal
  Non-cardiac surgery: Cardiovascular assessment and management - How to session?  
  Panel: Th. Carrel (Bern, CH); S. D. Kristensen (Aarthus, DK); M. Licker (Genève, CH); M. Roffi (Genève, CH)  
  What’s new ?   
  S. D. Kristensen (Aarthus, DK)  
  Case 1  
  P. Müller (Chur, CH)  
  Case 2  
  L. Altwegg (Basel, CH)  
  Case 3  
  E. De Benedetti (Mayrin, CH)  
  M. Roffi (Genève, CH)  
11:00 - 12:30 Workshop 8 Kammermusiksaal
  Heart failure: New therapeutic concepts  
  Vorsitz/Modération: M. Maeder (St. Gallen, CH); Ph. Meyer (Genève, CH)  
  Heart failure with reduced ejection fraction. Valsartan-Neprilysin-Inhibition - A paradigm change?  
  R. Hullin (Lausanne, CH)  
  Iron substitution in HF - Current evidence and a new concept?  
  O. Pfister (Basel, CH)  
  Mechanical Circulatory Support 2015 - An overview  
  P. Tozzi (Lausanne, CH)  
  Mechanical Circulatory Support - Can we afford it?  
  P. Mohacsi (Bern, CH)  
11:00 - 12:30 Workshop 9 Vortragssaal
  Translational research in cardiology - Maybe clinical reality tomorrow?  
  Vorsitz/Modération: B. Kaufmann (Basel, CH); Ch. Matter (Zürich, CH)  
  Cardiac regeneration - Picking up the pieces  
  G. Kuster Pfister (Basel, CH)  
  Molecular imaging with MRI - Ready for prime time?  
  R. van Heeswijk (Lausanne, CH)  
  The crossroad between immunology and artherosclerosis - Clinical implications  
  R. Klingenberg (Zürich, CH)  
  Impact of high-resolution, multimodal intracoronary imaging in patients with ACS  
  L. Räber (Bern, CH)  
  Genes in blood pressure  
  G. Ehret (Genève, CH)  
11:00 - 12:30 Scientific Session 2 Seezimmer 3
  Challenges in postoperative pain management  
  Vorsitz/Modération: M. Schärli-Purtschert (Aarau, CH); N. Zigan (Winterthur, CH)  
  What's the best pain medication for your patient?  
  T. Ries (Basel, CH)  
  Children's pain and withdrawal: Which interventions are necessary?  
  J. Stocker (Zürich, CH)  
  Do young adults need a special pain management program?  
  E. Schlupp (Zürich, CH); E. Horvath (Zürich, CH)  
  Post-operatove pain following cardiovascular surgery  
  M.-M. Jeitzinger (Bern, CH)  
11:00 - 12:30 Abstract Session 8 Seezimmer 2
  Device therapy and defibrillation  
  Vorsitz/Modération: B. Schär (Basel, CH), R. Kobza (Luzern, CH)  
  Conductor externalization and failure rate of the biotronik linox lead  

F. Noti*, A. Lam, N. Klossner, J. Seiler, H. Servatius, A. Medeiros-Domingo, N. Tran, J. Fuhrer, H. Tanner, L. Roten


Cardiology, Inselspital, Bern, Switzerland

  Role of bystander cardiopulmonary resuscitation and automatic external defibrillators use to improve survival in out-of-hospital cardiac arrest  

C. Benvenuti 2 *, M. L. Caputo 1, R. Mauri 2, T. Cassina 1, T. Moccetti 1, A. Del Bufalo 1, A. Gallino 2, C. Casso 2, C. Klersy 3, A. Auricchio 1


1Cardiocentro Ticino, Lugano, 2Fondazione Ticino Cuore, Breganzona, Switzerland, 3Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  New insights  into electromechanics in heart failure patients  

F. Maffessanti 1*, W. Kroon 1, M. Potse 1, F. Regoli 2, R. Murzilli 2, D. Suerder 2, T. Moccetti 2, F. W. Prinzen 3, R. Krause 1, A. Auricchio 1, 2


1Center for Computational Medicine in Cardiology, Institute of Computational Sciences, Università della Svizzera italiana, 2Cardiology, Cardiocentro Ticino, Lugano, Switzerland, 3Physiology, Cardiovascular Research Institute Maastricht, Maastricht, Netherlands

  Reassessment of risk factors and comorbidity burden at the time of first implantable cardioverter defibrillator replacement to determine subsequent use of ICD  

B. Schaer*, M. Kühne, T. Reichlin, St. Osswald, Ch. Sticherling, S. Niederberger


Cardiology, University Hospital, Basel, Switzerland

  Lead- and batteryless cardiac pacing  

A. Zurbuchen 1*, A. Haeberlin 1, 2, L. Bereuter 1, J. Wagner 1, J. Schaerer 1, A. Pfenniger 1, Ch. Huber 3, J. Fuhrer 2, R. Vogel 1, 4


1ARTORG Cardiovascular Engineering, University of Bern, 2Cardiology, 3Cardiovascular Surgery, Inselspital, Bern, 4Cardiology, Bürgerspital, Solothurn, Switzerland

  High recurrence rate of device-related adverse events following transvenous lead extraction procedure in CRT patients  

F. Regoli 1 *, M. Bongiorni 2, R. Rordorf 3, M. Santamaria 4, L. Segreti 2, V. Deregibus 3, T. Moccetti 1, G. Conte 1, M. L. Caputo 1, C. Klersy 5, A. Auricchio 1


1Cardiology, Fondazione Cardiocentro Ticino, Lugano, Switzerland, 2Cardiothoracic and Vascular Department, University Hospital, Pisa, 3Cardiology, IRCCS Fondazione Policlinico S. Matteo, Pavia, 4Cardiology, Cambobasso Hospital, Cambobasso, 5Servizio di Biometria e Statistica, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy

11:00 - 12:30 Abstract Session 9 Seezimmer 4
  Biomarkers and acute coronary syndromes  
  Vorsitz/Modération: St. Noble (Genève, CH); P. Bonetti (Chur, CH)  
  Basel-PMI: First results of a prospective swiss multicenter project on perioperative myocardial injury in non-cardiac surgery  

F. Cuculi 5 *, Ch. Puelacher 4, G. Lurati-Buse 1, M. Seeberger 6, L. Gürke 2, A. Lampart 1, R. Twerenbold 3, E. Seeberger 1, H. Singeisen 4, Ch. Müller 4


1Anesthesiology, 2Vascular Surgery, 3Cardiology, 4Cardiovascular Research Instiute Basel, University Hospital, Basel, 5Cardiology, Cantonal Hospital, Luzern, 6Anesthesiology, Hirslanden, Zürich, Switzerland

  Combining BNP and HS-CTNI in the evaluation of patients with suspected inducible myocardial ischemia  

Ch. Puelacher 1 *, R. Twerenbold 2, T. Reichlin 2, M. Wagener 1, G. Lee 1, Y. Tanglay 1, U. Honegger 1, N. Schaerli 1, G. Prêtre 1, Ch. Müller 1


1Cardiology, Cardiovascular Research Instiute Basel, 2Cardiology, University Hospital, Basel, Switzerland

  Effects of hemolysis on the diagnostic accuracy of cardiac troponin I for the diagnosis of myocardial infarction  

Ch. Puelacher 1 *, R. Twerenbold 2, T. Reichlin 2, P. Hillinger 1, M. Wagener 1, K. Rentsch 3, St. Osswald 2, Z. Moreno-Weidmann 1, Ch. Müller 1


1Cardiology, Cardiovascular Research Instiute Basel, 2Cardiology, 3Laboratory Medicine, University Hospital, Basel, Switzerland

  Frequency, reasons and predictors of unplanned cardiac rehospitalizations following primary PCI in stemi patients: Results of the comfortable AMI trial  

L. Räber1*, E. Spitzer 1, M. Frei 2, S. Hadorn 2, S. Zaugg 3, A. Baumbach 8, C. Von Birgelen 9, D. Tüller 4, M. Roffi 6, G. Pedrazzini 7, V. Vukcevic 9, K. Weber 9, R. Kornowski 9, A. Khattab 1, A. Moschovitis 1, B. Meier 1, Th. F. Lüscher 5, P. Jüni 3, St. Windecker 1


1Cardiology, Inselspital, 2Medizin, 3Social and Preventive Medicine, University of Bern, Bern, 4Cardiology, Triemli Hospital, 5Cardiology, University Hospital, Zürich, 6Cardiology, University Hospital, Genève, 7Cardiology, Cardiocentro, Lugano, Switzerland 8Cardiology, Hospital of Bristol, Bristol, United Kingdom, United States, 9Unknown

  Improved risk stratification of patients with acute coronary syndrome referred for invasive management with syntax II score beyond syntax and grace score  

S. Obeid 1 *, A. H. Frangieh 1, M. jaguszewski 6, S. Aghlmandi 3, Ch. Templin 1, P. Jüni 3, N. Rodondi 4, F. Mach 5, M. Roffi 5, St. Windecker 2, F. Nietlispach 1, Ch. Matter 1, R. Klingenberg 1, Th. Lüscher1


1Cardiology, University Hospital, Zürich, 2Cardiology, 3Clinical Research, 4General Internal Medicine, University of Bern, Bern, 5Cardiology, University Hospital, Genève, Switzerland, 6Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany

  Prevalence and prognostic significance of preprocedural high-sensitivity cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: Results from the Bern PCI registry  

Th. L. G.-L. Zanchin 1 *, L. Räber 1, D. Heg 3, C. O'Sullivan 4, K. Koskinas 1, A. Khattab 1, Th. Pilgrim 1, A. Moschovitis 1, St. Stortecky 1, S. Blöchlinger 1, A. Frenk 1, Ch. Moro 1, P. Wenaweser 1, B. Meier 1, P. Jüni 2, St. Windecker 1


1Cardiology, 2Social and Preventive Medicine, Inselspital, 3Social and Preventive Medicine, University of Bern, Bern, 4Cardiology, Triemli Hospital, Zürich, Switzerland

12:45 - 13:45 Generalversammlung WG KAP/ Seezimmer 4
  Assamblée générale WG KAP  
  Präsident/Président: G. Stoffel (Zürich, CH)  
13:00 - 14:00 Satellite Symposium Panoramasaal
  Novartis Pharma Schweiz AG: What`s new in chronic heart failure?  
Welcome & Introduction  
F. Mach (Genève, CH)  
Pathophysiology of heart failure - Targets for pharmacological therapy  
O. Pfister (Basel, CH)  
Novel therapeutic options in the treatment of chronic heart failure  
M. Böhm (Homburg, D)  
Panel discussion & questions from the audience  
Th. Suter (Bern, CH)  
13:00 - 14:00 Satellite Symposium Kammermusiksaal
  Bristol-Myers Squibb SA / Pfizer AG: New horizons in anticoagulation - Minimizing risks and optimising outcomes  
Welcome & Introduction  
B. Meier (Bern, CH)  
Anticoagulation in the elderly patient: Do's and dont's  
G. Noll (Zürich, CH)  
Eliquis (Apixaban); A promising new option for the management of deep vein thrombosis and pulmonary embolism  
B. Amann-Vesti (Zürich, CH)  
13:00 - 15:00 Workshop 10 Vortragssaal
  Vorsitz/Modération: H. Wehrli (Bern, CH); M. Zalundaro (Zürich, CH); Th. Brunner (St. Gallen, CH); P. Ammann (St. Gallen, CH); D. Weilenmann (St. Gallen, CH); A. Marty (Zürich, CH); P. Sonderegger (Zürich, CH); R. Binder (Zürich, CH)  
13:00 - 13:45 Workshop 11 Seezimmer 2
  Resistant Hypertension  
  Vorsitz/Modération: F. Messerli (New York, US); F. Muggli (Vezia, CH)  
13:00 - 14:00 Poster Walk in designated Poster Areas  
14:00 - 15:30 Workshop 12 Seezimmer 3
  In the heart of seamless transition - Who cares?  
  Vorsitz/Modération: C. Bläuer (Basel, CH); H. Rettke (Zürich, CH)  
  Shouldn't wait? - Triage of cardiac patients in the Emergency Department  
  F. Grossmann (Basel, CH)  
  Care of cardiac patients remains complex and critical even following discharge from the Intensive Care Unit: Working together is key  
  S. Haubner (Zürich, CH)  
  Monitoring after cardiac cath-lab interventions – How to provide safe patient care?  
  R. Bührer (Basel, CH)  
  Which children would benefit from rehabilitation?  
  G. Stoffel (Zürich, CH)  
  Older inpatients discharged home: How is nursing making a difference?  
  C. Mabire (Lausanne, CH)  
14:15 - 15:15 Workshop 13 Seezimmer 2
  Blutdruck unter Belastung  
  Vorsitz/Modération: I. Sudano (Zürich, CH); R. Brenner (St. Gallen, CH)  
14:15 - 15:15 Satellite Symposium Panoramasaal
  Daiichi Sankyo (Schweiz) AG: Vier gewinnt: Edoxaban - Das neue orale Antikoagulans  
Opening Remarks  
H. Rickli (St. Gallen, CH)  
Akutbehandlung und Prävention beim kartioembolischen Schlaganfall  
U. Fischer (Bern, CH)  
Edoxaban - Der neue Faktor-Xa-Hemmer  
J. Steffel (Zürich, CH)  
Einsatz der NOACs im klinischen Alltag  
J.-H. Beer (Baden, CH)  
14:15 - 15:15 Satellite Symposium Kammermusiksaal
  Sanofi Aventis (Schweiz) AG: Managing Dyslipidemia: What should a cardiologist know?  
  Vorsitz/Modération: F. Ruschitzka (Zürich, CH); St. Windecker (Bern, CH)  
Unmet medical need in the management of hypercholesterolemia  
F. Mach (Genève, CH)  
Familial hypercholesterolemia: What should a cardiologist know?  
A. von Eckardstein (Zürich, CH)  
ODYSSEY: A fascinating journey  

C. Müller (Basel, CH)

14:15 - 15:15 SSC Tarife Commission Seezimmer 4
  Vorsitz/Modération: G. Pedrazzini (Locarno, CH)  
15:30 - 17:00 Main Session 5 Panoramasaal
  Preoperative antithrombotic management  
  Vorsitz/Modération: J. Beer (Baden, CH); P. Ruchat (Lausanne, CH)  
  PJ Devereaux (Toronto, CH)  
  Dual platelet inhibition  
  J. Steffel (Zürich, CH)  
  OAC and NOAC with or without platelet inhibition  
  M. Filipovic (St. Gallen, CH)  
  Before cardiac surgery  
  St. Demertzis (Lugano, CH)  
15:30 - 17:00 Workshop 14 Kammermusiksaal
  Electrophysiology and interventionalists at the crossroad  
  Vorsitz/Modération: Ch. Sticherling (Basel, CH); P. Wenaweser (Bern, CH)  
  Left atrial appendage occluder: The electrophysiologists view  
  M. Kühne (Basel, CH)  
  Left atrial appendage occluder: The interventionalists view  
  F. Nietlispach (Zürich, CH)  
  Arrhythmias in acute coronary syndrome  
  E. Pruvot (Lausanne, CH)  
  Coronary stenting and atrial fibrillation: What's the right regimen for oral anticoagulation?  
  G. Pedrazzini (Lugano, CH)  
  Pacing indication before and after TAVI  
  St. Toggweiler (Luzern, CH)  
15:30 - 17:00 Workshop 15 Vortragssaal
  Iatrogenic heart failure  
  Vorsitz/Modération: St. Krähenbühl (Basel, CH); F. Ruschitzka (Zürich, CH)  
  Cancer-Drug induced heart failure  
  Th. Suter (Bern, CH)  
  Heart failure in patients with rheumatologic diseases  
  R. Hullin (Lausanne, CH)  
  Heart failure during and after anesthesia  
  M. Licker (Genève, CH)  
  Tachycardia-induced heart failure - Does it exist?  
  E. Delacrétaz (Lausanne, CH)  
15:30 - 17:00 Workshop 16 Seezimmer 2
  All about HCM  
  Vorsitz/Modération: H. Müller (Genève, CH); X. Jeanrenaud (Lausanne,CH)  
  Phenotypes and genotypes of HCM  
  St. R. Ommen (Rochester, US)  
  Echocardiography and CRM in HCM  
  St. Muzzarelli (Lugano, CH)  
  Alcohol ablation or LVOT surgery: When and what  
  P Vogt (Zürich, CH)  
  Alcohol ablation or LVOT surgery: When and what  
  O. Bertel (Zürich, CH)  
  Noninvasive treatment options in HCM  
  Ch. Gruner (Zürich, CH)  
  HCM: What is new in the guidelines? Impact on our practice  
  St. R. Ommen (Rochester, US)  
15:30 - 17:00 Abstract Session 10 Seezimmer 4
  Cellular mechanisms of cardiovascular disease  
  Vorsitz/Modération: N. Rosenblatt (Genève, CH), Ch. Matter (Zürich, CH)  
  Assessment of myocardial oxidative metabolism during ischemia/reperfusion in the intact rat model by hyperpolarized 13C-pyruvate mr spectroscopy  

H. A. I. Yoshihara 1*, J. A. M. Bastiaansen 2, C. Berthonneche 4, A. Comment 5, J. Schwitter 3


1Cardiology, 2Radiology, 3Cardiology and Cardiac MR Center, 4Cardiovascular Assessment Facility, CHUV, 5Institute of Physics of Biological Systems, EPFL, Switzerland

  T-cadherin promotes vascular smooth muscle cell phenotype switch by a novel cadherin-β-catenin-dependent mechanism  

A. Frismantiene 1 *, B. Dasen 1, D. Pfaff 1, P. Erne 2, Th. Resink 1, M. Filippova 1


1Biomedicine, University Hospital and University of Basel, Basel, 2Hirslanden, Luzern, Switzerland

  JNK inhibition mimics the improvement in endothelial function by roux-en-y gastric bypass surgery in diet-induced obese rats  

P. Doytcheva 2*, E. Osto 2, Th. Bächler 1 3, E. Tarasco 1, M. Büter 3, Ch. Matter 2, Th. A. Lutz 1, Th. Lüscher 2


1Veterinary Physiology, University of Zurich, Zürich, 2Center for Molecular Cardiology, University of Zurich, Schlieren, 3Surgery, University Hospital, Zürich, Switzerland

  Human cardiac progenitor cells injected into the peri-infarct region inhibit cardiomyocyte apoptosis, increase blood vessel formation, reduce scar and improve cardiac function at 1 and 4 weeks after acute myocardial infarction in rats  

L. Barile*, E. Cervio, T. Torre, T. Moccetti, G. Vassalli

  Cardiocentro Ticino, Lugano, Switzerland  
  Human cardiac progenitor cells release exosomes containing cardioprotective and proangiogenic micrornas: Functional analysis of these micrornas and identification of their target genes  

E. Cervio *, L. Barile, T. Torre, T. Moccetti, G. Vassalli

  Cardiocentro Ticino, Lugano, Switzerland  
  Role of sildenafil in the recruitment of hematopoietic progenitor cells in hypoxia-induced pulmonary hypertension  

S. Favre 1 *, G. Milano, P. Bianciardi 2, L. K. von Segesser 1, M. Samaja 2


1CHUV, Lausanne, Switzerland, 2University of Milan, Milan, Italy

17:15 - 18:15 Satellite Symposium Panoramasaal
  Boston Scientific: Optimal healing and DAPT duration for Complex PCI: The Synergy stent  
Vorsitz/Modération: St. Windecker (Bern, CH); St. Cook (Fribourg, CH)  
Introduction / Bioresorbable polymer DES - Are they all the same?  
R. Byrne (München, DE)  
EVOLVE II, 1 year  
St. Windecker (Bern, CH)  
Complex PCI and DAPT decisions in real world  
St. Cook (Fribourg, CH)  
Optimal revascularization in CTO  
S. Walsh (Belfast, IRL)  
17:15 - 18:15 Satellite Symposium Kammermusiksaal
  Bayer (Schweiz) AG: NOAC's in Cardiology: Transferring clinical data into clinical practice  
Efficacy, safety & cardiovascular profile of Rivaroxaban  
H. Rickli (St. Gallen, CH)  
NOAC's in AF patients undergoing cardioversion: what the clinical data tell us  
M. Kühne (Basel, CH)  
NOAC's in AF patients: Real-life experience & patient management  
J. Steffel (Zürich, CH)  
17:15 - 18:15 Workshop 17 Vortragssaal
  Vorsitz/Modération: A. Menafoglio (Bellinzona, CH); G. Fiori (Locarno, CH); J. Schläpfer (Lausanne, CH); Th. Wolber (Zürich, CH)  
17:15 - 18:15 SGK Quiz Seezimmer 3
Vorsitz/Modération: F. Messerli (New York, US)  
17:15 - 18:15 Abstract Session 11 Seezimmer 2
  Heart Surgery  
  Vorsitz/Modération: U. Niederhäuser (Bern, CH); Th. Suter (Bern, CH)  
  Beta-adrenergic receptor polymorphism and maximal exercise capacity after orthotopic heart transplantation  

R. Hullin 1*, F. Mehmeti 3, D. Martin 1, P. Yerly 1, P. Tozzi 2, Ph. Meyer 3, M. Metrich 1 on behalf of Swiss Transplant Cohort Study


1Cardiology, 2Cardiac Surgery, CHUV, Lausanne, 3Cardiolgy, University Hospital, Genève, Switzerland

  Impact of percutaneous mitral valve repair using the Mitraclip™ system on tricuspid regurgitation  

O. Gämperli 1*, A. H. Frangieh 1, C. Gruner 2, F. Mikulicic 6, A. Attinger-Toller 1, F. C. Tanner 2, M. Taramasso 5, R. Corti 7, J. grünenfelder 8, T. F. Lüscher 1, F. Ruschitzka 3, D. Bettex 4, F. Maisano 5


1Interventional Cardiology, 2Echocardiography, 3Cardiology, 4Anesthesiology, 5Cardiac Surgery, 6University Hospital, Zürich, Switzerland, 7Interventional Cardiology, 7Cardiac Surgery, Hirslanden, Zürich, Switzerland

  Long-term follow-up after percutaneous mitral valve repair using the mitraclip system  

A. Attinger-Toller 1*, J.-N. Yoon 1, A. H. Frangieh 1, Ch. Gruner 1, J. Vontobel 1, M. Taramasso 2, R. Corti 3, Th. Lüscher 1, D. Bettex 4, F. Ruschitzka 1, F. Maisano 1, O. Gämperli 1


1Cardiology, 2Cardiovascular Surgery, University Heart Center, 3Cardiology, Hirslanden, 4Cardiac Anesthesiology, University Heart Center, Zürich, Switzerland

  Multicenter-trail on home discharge of children on HVAD heartware LVAD  

M. Schweiger 1*, Ch. Vanderpluym 5, M. Huebler 1, J. Schmitto 3, M. Mehegan 6, Ch. E. Canter 6, A. Adachi 5, A. Jeewa 7, P. Jansz 9, P. E. Parrino 8, O. Miera 2, D. Zimpfer 4


1Congenital Cardiovascular Surgery, Children’s Hospital, Zürich, Switzerland, 2Heart Institute, Berlin, 3Cardio-,Thoracic-, Transplantation-, and Vascular Surgery, Medical School, Hannover, Germany, 4Cardiac Surgery, Medical University, Vienna, Austria, 5Children’s Hospital, Boston, 6Children’s Hospital, St. Louis, 7Children’s Hospital, Texas, 8Ochsner Medical Centre, New Orleans, United States, 9St. Vincent's Hospital, Sydney, Australia

  Outcomes of minimally invasive mitral valve surgery in elderly patients >75 years of age  

D. Reser*, T. Holubec, H. Tolboom, M. Emmert, E. Caliskan, A. Plass, A. Weber, St. Benussi, F. Maisano


Cardiac Surgery, University Hospital, Zürich, Switzerland

  Is minimally invasive mitral valve repair with artificial chords reproducible and applicable in routine surgery?  
  A. Panos 1*, P. Myers 2  

1Cardiovascular Surgery, Clinic de la Colline, 2Cardiovascular Surgery, University Hospital, Genève, Switzerland

19:00 - 24:00 Gesellschaftsabend/Dîner Convival